Methylene Blue, a broad-spectrum inflammasome inhibitor 65, and CASP1 siRNAs were used to suppress inflammasome signaling activation, reflected by decreased IL-1β expression, in cancer cells (Figure S20A-C, Figure S21A-B). This evidence concerns the gene CASP1 and cancer.